Bionic pancreas device approved for home-use clinical study in US

Edward R. Damiano | Via Diabetes Digital Media | May 22, 2018

The US Food and Drug Administration (FDA) has given permission for a dual-hormone artificial pancreas, dubbed the bionic pancreas, to be used in the homes of people with type 1 diabetes.

It is thought the pioneering iLet device could revolutionise diabetes treatment as it mimics the way a pancreas works, delivering insulin, glucagon or a combination. However, in the trial which has been given approval, the device will deliver just insulin.

The iLet has been developed by Edward Damiano, PhD, president of Boston-based Beta Bionics, who is aiming to have the device fully approved by official bodies in the foreseeable future. He introduced it to the world in 2015, calling it a “bridge to a cure” for type 1 diabetes.

The FDA has now given the go ahead for home-use clinical studies… Continue reading.